Europe Syndromic Multiplex Diagnostic Market research report works as a best solution to know the trends and opportunities in the HEALTHCARE industry. The report has been framed with the most excellent and superior tools of collecting, recording, estimating and analysing market data. This report gives broader perspective of the market place with its all-inclusive market insights and analysis. The information, statistics, facts and figures delivered via this report helps companies in HEALTHCARE industry to maximize or minimize the production of goods depending on the conditions of demand.
According to a World Health Organization (WHO) report updated in September 2021, more than 55 million people worldwide live with dementia, and nearly 10 million new cases are diagnosed each year, with Alzheimer's disease (AD) accounting for the majority of cases. Several multiplex panels have been developed to detect such rare diseases. For example, the April 2021 article "Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes" stated that the study's researchers developed a multiplex-PCR (polymerase chain reaction) based diagnostic method that demonstrated the rapid and accurate detection of AD biomarkers. Such advancements and research increase the demand for syndromic multiplex diagnostics, propelling the market forward.
Data Bridge Market Research analyses that the syndromic multiplex diagnostic market which is USD 3879.99 million in 2022, is expected to reach USD 7562.53 million by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/europe-syndromic-multiplex-diagnostic-market
Some of the major players operating in the syndromic multiplex diagnostic market are:
- Seegene Inc. (South Korea)
- Luminex Corporation (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Danaher (U.S.)
- QIAGEN (Germany)
- Abbott (U.S.)
- Hologic, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Siemens Healthcare GmbH (Germany)
- Biocartis (Belgium)
- QuantuMDx Group Ltd. (U.K.)
- Bosch Healthcare Solutions GmbH (Germany)
- Prominex Inc. (U.S.)
- Curetis (Germany)
Syndromic multiplex diagnostic testing is a type of advanced diagnostic test used to detect infectious diseases such as respiratory infection, infective gastroenteritis, sexually transmitted infections, sepsis, and meningitis, among others. The syndromic multiplex diagnostic also aids clinicians and hospitals in detecting the symptoms and signs of various diseases. This allows health care providers to provide the best treatment for their patients while also providing more precise outcomes and care that can be delivered more quickly.
Browse More Reports:
https://www.databridgemarketresearch.com/reports/global-sicca-syndrome-sjogren-market
https://www.databridgemarketresearch.com/reports/global-cough-hypersensitivity-syndrome-market
Global Syndromic Multiplex Diagnostic Market
https://www.databridgemarketresearch.com/reports/asia-pacific-syndromic-multiplex-diagnostic-market
https://www.databridgemarketresearch.com/reports/north-america-syndromic-multiplex-diagnostic-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
